ANAGRELIDE | ANAGRELIDE | ATC L01XX35
ANTINEOPLASTIC REDUCES BLOOD PLATELET COUNT TREATMENT OF ESSENTIAL-THROMBOCYTHAEMIA (ET) | ORAL | Tmax 1 HOUR F 70 PERCENT HT 1.5 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER | CYCLIC AMP PHOSPHODIESTERASE III | PHOSPHODIESTERASE 3 INHIBITOR CHEMBL2094125 PHOSPHODIESTERASE 3 Q13370 CGMP-INHIBITED 3',5'-CYCLIC PHOSPHODIESTERASE B HOMO SAPIENS ENZYME PHOSPHODIESTERASE PDE_3 PDE_3B | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |